Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2016 Sep 19;44(1):17–24. doi: 10.1007/s00259-016-3520-4

Figure 3.

Figure 3

Overall survival (OS) by radiation dose delivered in the low- and high-pretreatment metabolic tumor volume groups. (A) Patients with pre-treatment tMTV (tMTV-pre) below the median (32mL, “Low tMTV-pre group”) are divided based on radiation dose. (B) Patients with tMTV-pre above the median (32mL, “High tMTV-pre group”) are divided based on radiation dose.